Protalix BioTherapeutics Q3 Earnings: $2.4M Net Income, $17.9M Revenue
Update: 2025-11-13
Description
Protalix BioTherapeutics, a pharmaceutical company, reported earnings of $2.4 million for Q3, translating to a net income of $0.03 per share. Revenue stood at $17.9 million, offering insights into the companys financial health and market position.
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
1.0x
